ES2141384T3 - Fabricacion de levobupivacaina y analogos de la misma a partir de l-lisina. - Google Patents

Fabricacion de levobupivacaina y analogos de la misma a partir de l-lisina.

Info

Publication number
ES2141384T3
ES2141384T3 ES95933512T ES95933512T ES2141384T3 ES 2141384 T3 ES2141384 T3 ES 2141384T3 ES 95933512 T ES95933512 T ES 95933512T ES 95933512 T ES95933512 T ES 95933512T ES 2141384 T3 ES2141384 T3 ES 2141384T3
Authority
ES
Spain
Prior art keywords
pct
levobupivacaine
lysine
analogs
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95933512T
Other languages
English (en)
Inventor
Gordon Eric Hutton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Darwin Discovery Ltd
Original Assignee
Darwin Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9420243A external-priority patent/GB9420243D0/en
Priority claimed from GBGB9504928.4A external-priority patent/GB9504928D0/en
Application filed by Darwin Discovery Ltd filed Critical Darwin Discovery Ltd
Application granted granted Critical
Publication of ES2141384T3 publication Critical patent/ES2141384T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/26—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/72—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/73—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton to carbon atoms of non-condensed six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

SE PREPARA UN NUEVO COMPUESTO DE FORMULA (X) A PARTIR DE LLISINA, Y SE CONVIERTE EN LEVOBUPIVACAINA MEDIANTE PRODUCCION EN CICLOS.
ES95933512T 1994-10-07 1995-10-09 Fabricacion de levobupivacaina y analogos de la misma a partir de l-lisina. Expired - Lifetime ES2141384T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9420243A GB9420243D0 (en) 1994-10-07 1994-10-07 Complex and its use
GBGB9504928.4A GB9504928D0 (en) 1995-03-10 1995-03-10 Diazotisation and cyclisation

Publications (1)

Publication Number Publication Date
ES2141384T3 true ES2141384T3 (es) 2000-03-16

Family

ID=26305755

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95933512T Expired - Lifetime ES2141384T3 (es) 1994-10-07 1995-10-09 Fabricacion de levobupivacaina y analogos de la misma a partir de l-lisina.

Country Status (9)

Country Link
US (1) US5929242A (es)
EP (1) EP0784608B1 (es)
JP (1) JP3970925B2 (es)
AT (1) ATE187958T1 (es)
AU (1) AU695348B2 (es)
DE (1) DE69514115T2 (es)
ES (1) ES2141384T3 (es)
MX (1) MX9702486A (es)
WO (1) WO1996011181A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2234975T3 (pl) 2008-01-15 2012-09-28 Pharmathen Sa Proces wytwarzania 2',6'-ksylidydu kwasu 2-pipekolinowego stosowanego jako produkt pośredni do przygotowywania środków miejscowo znieczulających
CN111548303A (zh) * 2020-06-28 2020-08-18 山东美泰医药有限公司 一种盐酸左布比卡因的杂质及其制备和分析方法

Also Published As

Publication number Publication date
US5929242A (en) 1999-07-27
ATE187958T1 (de) 2000-01-15
JP3970925B2 (ja) 2007-09-05
DE69514115D1 (de) 2000-01-27
DE69514115T2 (de) 2000-04-20
EP0784608B1 (en) 1999-12-22
EP0784608A1 (en) 1997-07-23
MX9702486A (es) 1998-04-30
JPH10507173A (ja) 1998-07-14
AU695348B2 (en) 1998-08-13
WO1996011181A1 (en) 1996-04-18
AU3614295A (en) 1996-05-02

Similar Documents

Publication Publication Date Title
ATE191334T1 (de) Hydrophilierte zahnabdruckmassen
EA199800290A1 (ru) (метилсульфонил) фенил-2-(5н)-фураноны в качестве ингибиторов циклооксигеназы-2
MD1315B1 (en) Oxim esters and intermediate compositions, process for preparation thereof, compositions, process for pests control.
ATE272398T1 (de) Verwendung von ep4 rezeptorliganden zur behandlung von neuropathischen schmerz
NO178764C (no) Fremgangsmåte ved fremstilling av oksetanoner
HUP9802859A2 (hu) Acil-amino-szalicilsav-amid-származékok és alkalmazásuk peszticidként
PL344048A1 (en) Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
MY132473A (en) Crystalline hydrochloride of (r)-(-)-2-<n-[4-(1,1- dioxido-3-oxo-2,3-dihydro-benzisothiazol-2-yl)-butyl]-aminomethyl>-chroman
IL160045A0 (en) Oxopyrrolidine compounds, preparation of said compounds and their use in the manufacturing of levetiracetam and analogues
BG101893A (en) Nodulosporic acid derivatives
ATE194995T1 (de) Polymerisationsfähige derivate von polyamiden
DE69823662D1 (de) 1,4,7,10-tetraazabicyclo(8.2.2)tetradecan-2-on, verfahren zu ihrer herstellung und ihrer verwendung für die herstellung von tetraazamacrocyclen
DE69723728D1 (de) Totalsynthese des amino hip analogen von didemnin a
DK0850231T3 (da) Fremgangsmåde til fremstilling af en 2-chlor-5-chlormethyl-thiazolforbindelse
EA200300579A1 (ru) Соединение лактама
TR200503401T1 (tr) Kuetiapin (Quetiapine) Fumarat'ın yeni polimorfları
DK0787124T3 (da) Fremgangsmåde til fremstilling af substituerede 3-aminobenzonitriler
ATE257139T1 (de) Ein (1'r,2's,5'r)-3-l-menthoxypropan-1-ol, das eine kühlende empfindung erzeugt
BG104232A (bg) Заместени 1,2,3,4,5,6-хексахидро-2,6-метано-3-бензазоцин- 10-оли, метод за тяхното получаване и приложението им като лекарствени средства
ATE60768T1 (de) Verfahren zur herstellung von thienylaethylaminen, und mittels des verfahrens hergestellte dithienylaethylamine.
ATE275561T1 (de) Verfahren zur herstellung von pantoprazol und zwischenprodukte dieses verfahrens
ES2141384T3 (es) Fabricacion de levobupivacaina y analogos de la misma a partir de l-lisina.
GR3017348T3 (en) Novel isoindolinone derivative, preparation thereof, and pharmaceutical compositions containing same.
DE50309260D1 (de) Verfahren zur herstellung von bicalutamid
DE60224884D1 (de) Verfahren zur herstellung von 3, 3', 6, 6'-tetraalkylen-2, 2'-biphenolen und 3, 3', 6, 6'-tetraalkylen-5, 5'-dihalo-2, 2' biphenolen

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 784608

Country of ref document: ES